MiNK Therapeutics(INKT) - 2023 Q4 - Earnings Call Transcript

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Conference Call March 21, 2024 8:30 AM ET Company Participants Zack Armen - Head, Investor Relations Jennifer Buell - President and Chief Executive Officer Marc Van Dijk - Chief Scientific Officer Christine Klaskin - Principal Financial and Accounting Officer Conference Call Participants Emily Bodnar - H.C. Wainwright Jack Allen - Baird Mayank Mamtani - B. Reilly Securities Operator Good day, everyone, and welcome to the MiNK Therapeutics' Fourth Quarte ...